{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:54:52Z","timestamp":1789073692558,"version":"build-2803163510"},"reference-count":94,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016198","name":"Idorsia Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/14737175.2026.2639557","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:10:30Z","timestamp":1773331830000},"page":"325-340","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Daridorexant: exploring its role in the treatment of insomnia disorder"],"prefix":"10.1080","volume":"26","author":[{"given":"Yaroslav","family":"Winter","sequence":"first","affiliation":[{"name":"Saarland University Medical Center, University of Saarland","place":["Homburg, Germany"]},{"name":"Philipps-University Marburg","place":["Marburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Policlinico San Martino","place":["Genoa, Italy"]},{"name":"University of Genoa","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0970"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13928"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14256"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12967"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.1.85"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2022.03.003"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18782"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.01.026"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnur.2020.10.012"},{"issue":"3","key":"e_1_3_5_13_1","first-page":"28","article-title":"Comorbid insomnia and psychiatric disorders: an update","volume":"15","author":"Khurshid KA","year":"2018","unstructured":"Khurshid KA. Comorbid insomnia and psychiatric disorders: an update. Innov Clin Neurosci. 2018;15(3\u20134):28\u201332.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2011.01.005"},{"key":"e_1_3_5_15_1","volume-title":"The societal and economic burden of insomnia in adults: an international study","author":"Hafner M","year":"2023","unstructured":"Hafner M, Romanelli RJ, Yerushalmi E. The societal and economic burden of insomnia in adults: an international study. Santa Monica (CA): RAND Corporation; 2023."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14035"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175"},{"key":"e_1_3_5_18_1","unstructured":"Almasi A Patel P Meza C. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542306\/"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1179573518770672"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100528"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7282"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1768667"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.241596"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05954-0"},{"key":"e_1_3_5_26_1","unstructured":"QUVIVIQ (daridorexant) summary of product characteristics. [cited 2026 Feb 24]. Available http:\/\/www.ema.europa.eu\/en\/documents\/product-information\/quviviq-epar-product-information_en.pdf"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.05.009"},{"key":"e_1_3_5_28_1","volume-title":"Committee for medicinal products for human use (CHMP): 21\u201324 February 2022","author":"European Medicines Agency","year":"2022","unstructured":"European Medicines Agency. Committee for medicinal products for human use (CHMP): 21\u201324 February 2022. 2022 Feb 24 (EMA\/187589\/2022)."},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1046"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2559-5"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00768-8"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.05.005"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13370"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001182"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119882854"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15029"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01028-8"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13079"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01310-6"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-024-00456-8"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2455"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14302"},{"key":"e_1_3_5_43_1","unstructured":"QUVIVIQ (daridorexant) tablets for oral use. US prescribing information. 2022."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25680"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009475"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.07.037"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00436-1"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00980-8"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.07.036"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaf170"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.511"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-020-00474-z"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-022-00977-4"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.506"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41606-023-00089-x"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.07.019"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2024.2359891"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.70135"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2025.108821"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.106523"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.07.005"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.098"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.70002"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8568"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae098"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-01020-9"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae067.0415"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093240"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07326-w"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14196"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.70158"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa275"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13248"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2592"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241293997"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab224"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01062-1"},{"key":"e_1_3_5_79_1","unstructured":"Azienda Ospedaliero. Prospective observational study on the effectiveness of daridorexant in chronic insomnia in a real-world setting [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07132086"},{"key":"e_1_3_5_80_1","unstructured":"Jean Lachaine PeriPharm. Real-world observational study on patient-reported outcomes in the treatment of insomnia with Daridorexant in Canada [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06311864"},{"key":"e_1_3_5_81_1","unstructured":"Suzanne M. Bertisch MD MPH Brigham and Women\u2019s Hospital. Comparing digital therapy Trazodone and daridorexant for menopause-related insomnia symptoms (CELESTE) [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07136415"},{"key":"e_1_3_5_82_1","unstructured":"Idorsia Pharmaceuticals Ltd. Database study to provide information on pregnancy and infant outcomes among women exposed to QUVIVIQ (daridorexant) [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06393504"},{"key":"e_1_3_5_83_1","unstructured":"Global Coalition for Adaptive Research. Department of defense PTSD adaptive platform trial - intervention C - Daridorexant [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05948540"},{"key":"e_1_3_5_84_1","unstructured":"University Hospital Montpellier. Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate alzheimer disease (DARIDOR-ALZ) [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05924425"},{"key":"e_1_3_5_85_1","unstructured":"Idorsia Pharmaceuticals Ltd. Dose-finding study assessing the efficacy safety and pharmacokinetics of daridorexant in subjects aged 10 to <18 years with insomnia disorder [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05423717"},{"key":"e_1_3_5_86_1","unstructured":"Idorsia Pharmaceuticals Ltd. Product monograph [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/pdf.hres.ca\/dpd_pm\/00070459.PDF"},{"key":"e_1_3_5_87_1","unstructured":"Idorsia Pharmaceuticals Ltd. QUVIVIQ\u00ae (active substance: daridorexant) [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/about-us\/publications\/public-summary-swiss-par\/public-summary-swiss-par-quviviq.html"},{"key":"e_1_3_5_88_1","unstructured":"Idorsia Pharmaceuticals Ltd. QUVIVIQ public assessment report [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/ed2aeb19a5f58327b069031bc07c8f3a3ad2dec2"},{"key":"e_1_3_5_89_1","unstructured":"Shionogi & Co Ltd. SHIONOGI and Nxera Pharma launch QUVIVIQ in Japan for adults with insomnia [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/www.shionogi.com\/global\/en\/news\/2024\/12\/2024_1219_2.html"},{"key":"e_1_3_5_90_1","unstructured":"Simcere Pharmaceutical Group Limited. Simcere Pharmaceutical group Limited Announces Approval for Marketing of QUVIVIQ in China by the National Medical products administration [Internet]. [cited 2026 Feb 12]. Available from: https:\/\/www.marketscreener.com\/quote\/stock\/SIMCERE-PHARMACEUTICAL-GR-119080130\/news\/Simcere-Pharmaceutical-Group-Limited-Announces-Approval-for-Marketing-of-QUVIVIQ-in-China-by-the-Nat-50296874\/"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101921"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleepe.2023.100061"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0349.2010.00722.x"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1233201"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.01.033"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1614562"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2026.2639557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:49:57Z","timestamp":1775040597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2026.2639557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/14737175.2026.2639557"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2026.2639557","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}